Topic · page 46 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 1,801–1,840 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

JAMA Cardiol1 Jul 2023
Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved Trial
Secondary analysis
Eur J Heart Fail29 Jun 2023
Coronary Revascularization for Heart Failure with Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials
Meta-analysis
Eur J Heart Fail29 Jun 2023
Eligibility for Vericiguat in a Real-World Heart Failure Population According to Trial, Guideline and Label Criteria: Data from the Swedish Heart Failure Registry
Cohort study
JACC Heart Fail28 Jun 2023
Distinct Impact of Noncardiac Comorbidities on Exercise Capacity and Functional Status in Chronic Heart Failure
Secondary analysis
JACC Heart Fail28 Jun 2023
Racial and Ethnic Disparities in Ambulatory Heart Failure Ventricular Assist Device Implantation and Survival
Cohort study
JACC Cardiovasc Imaging28 Jun 2023
Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-Amylo
Diagnostic or prognostic study
Eur J Heart Fail27 Jun 2023
Association Between a Hospitalization for Heart Failure and the Initiation/Discontinuation of Guideline-Recommended Treatments: An Analysis from the Swedish Heart Failure Registry
Cohort study
Eur J Heart Fail27 Jun 2023
Evolocumab has no Effects on Heart Failure with Reduced Ejection Fraction Injury Biomarkers: The EVO-HF Trial
Randomised controlled trial
Eur J Heart Fail27 Jun 2023
Hypoxaemia in Patients with Heart Failure and Preserved Ejection Fraction
Cross-sectional study
JACC Heart Fail21 Jun 2023
Mortality, Outcomes, Costs, and Use of Medicines Following a First Heart Failure Hospitalization: EVOLUTION HF
Cohort study
JACC Cardiovasc Imaging21 Jun 2023
Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy
Diagnostic or prognostic study
Eur J Prev Cardiol21 Jun 2023
A novel polygenic risk score improves prognostic prediction of heart failure with preserved ejection fraction in the Chinese Han population
Diagnostic or prognostic study
Eur J Heart Fail20 Jun 2023
Comparison of Pulmonary Congestion Severity Using Artificial Intelligence-Assisted Scoring Versus Clinical Experts: A Secondary Analysis of BLUSHED-AHF
Secondary analysis
JACC Heart Fail14 Jun 2023
Opportunities and Achievement of Medication Initiation Among Inpatients With Heart Failure With Reduced Ejection Fraction
Cohort study
Eur J Heart Fail8 Jun 2023
Effects of Dapagliflozin on Heart Failure Hospitalizations According to Severity of Inpatient Course: Insights from DELIVER and DAPA-HF
Secondary analysis
Eur J Heart Fail8 Jun 2023
Renal and Blood Pressure Effects of Dapagliflozin in Recently Hospitalized Patients with Heart Failure with mildly reduced or Preserved Ejection Fraction: Insights from the DELIVER Trial
Secondary analysis
Eur J Heart Fail7 Jun 2023
Effect of Dapagliflozin on Health Status and Quality of Life Across the Spectrum of Ejection Fraction: Participant-Level Pooled Analysis from the DAPA-HF and DELIVER Trials
Meta-analysis
Eur J Heart Fail6 Jun 2023
Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term Registry
Cohort study
Eur J Heart Fail4 Jun 2023
Incremental Prognostic Value of Biomarkers in PARADIGM-HF
Secondary analysis
Eur J Heart Fail4 Jun 2023
Prevalence, Characteristics and Cardiovascular and Non-Cardiovascular Outcomes in Patients with Heart Failure with Supra-Normal Ejection Fraction: Insight from the JROADHF Study
Cohort study
Eur J Heart Fail1 Jun 2023
Clinical Characteristics of Heart Failure with Reduced Ejection Fraction Patients with Rare Pathogenic Variants in Dilated Cardiomyopathy-Associated Genes: A Subgroup Analysis of the PARADIGM-HF Trial
Secondary analysis
JACC Heart Fail31 May 2023
Late Right Heart Failure After Left Ventricular Assist Device Implantation: Contemporary Insights and Future Perspectives
Research article
JACC Cardiovasc Imaging31 May 2023
Cardiac Computed Tomography for Quantification of Myocardial Extracellular Volume Fraction: A Systematic Review and Meta-Analysis
Meta-analysis
Eur J Heart Fail29 May 2023
Patient Profiles in Heart Failure with Reduced Ejection Fraction: Prevalence, Characteristics, Treatments and Outcomes in a Real-World Heart Failure Population
Cohort study
JACC Heart Fail24 May 2023
Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Secondary analysis
JACC Heart Fail24 May 2023
Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk
Secondary analysis
JACC Heart Fail24 May 2023
Long-Term Exposure to Road Traffic Noise and Incident Heart Failure: Evidence From UK Biobank
Cohort study
JACC Cardiovasc Imaging24 May 2023
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry
Cohort study
Eur Heart J23 May 2023
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
Secondary analysis
Eur J Heart Fail23 May 2023
Hyponatraemia and Changes in Natraemia During Hospitalization for Acute Heart Failure and Associations with In-Hospital and Long-Term Outcomes – from the ESC-HFA EORP Heart Failure Long-Term Registry
Cohort study
Eur Heart J22 May 2023
Conventional heart failure therapy in cardiac ATTR amyloidosis
Cohort study
Eur Heart J22 May 2023
NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial
Secondary analysis
Eur Heart J22 May 2023
Telemonitoring for heart failure: a meta-analysis
Meta-analysis
Eur Heart J21 May 2023
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
Randomised controlled trial
J Am Coll Cardiol21 May 2023
Comparison of Left Bundle Branch Area Pacing and Biventricular Pacing in Candidates for Resynchronization Therapy
Cohort study
J Am Coll Cardiol21 May 2023
Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure
Randomised controlled trial
Eur J Prev Cardiol21 May 2023
Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander?
Cohort study
Eur Heart J20 May 2023
Efficacy of pulmonary artery pressure monitoring in patients with chronic heart failure: a meta-analysis of three randomized controlled trials
Meta-analysis
J Am Coll Cardiol18 May 2023
Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy
Cohort study
JACC Heart Fail17 May 2023
Pre–Heart Failure Longitudinal Change in a Hispanic/Latino Population-Based Study: Insights From the Echocardiographic Study of Latinos
Cohort study

All 1,928 Briefs in ExploreShowing Briefs 1,801–1,840 of 1,928, newest first